# A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

> **NCT00234988** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 93 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** sibutramine hydochloride monohydrate

## Key facts

- **NCT ID:** NCT00234988
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2008-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234988, "A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00234988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*